Medtronic Estimates 2,400 Patients Eligible For Activa Dystonia Indication

Medtronic may pursue full PMA approval of its Activa brain stimulation technology to treat dystonia, upon determining which patients react well to the therapy under a humanitarian device exemption

More from Archive

More from Medtech Insight